← back to search

Christopher Tomlinson

Farr Institute · GB
Area of research
Infectious Diseases · Oncology
Research interest
Research interests include COVID-19 Clinical Research Studies, COVID-19 and healthcare impacts, Infant Development and Preterm Care, and Neonatal Respiratory Health Research.
h-index
20
citations
1,685
works
92
NIH funding
primary concept
Medicine
email

Recent publications

Prevalence and demographics of 331 rare diseases and associated COVID-19-related mortality among 58 million individuals: a nationwide retrospective observational study
The Lancet Digital Health 2025cited by 12position: middledoi
Burden of cardiovascular diseases in England (2020–24): a national cohort using electronic health records data
The Lancet Public Health 2025cited by 3position: middledoi
Ethnic disparities in COVID-19 mortality and cardiovascular disease in England and Wales between 2020-2022
Nature Communications 2025cited by 3position: middledoi
Proteomic signatures improve risk prediction for common and rare diseases
Nature Medicine 2024cited by 182position: middledoi
Vaccinations, cardiovascular drugs, hospitalization, and mortality in COVID-19 and Long COVID
International Journal of Infectious Diseases 2024cited by 9position: middledoi
Routine measurement of cardiometabolic disease risk factors in primary care in England before, during, and after the COVID-19 pandemic: A population-based cohort study
PLoS Medicine 2024cited by 5position: middledoi
Are ethnic disparities in COVID-19 severe outcomes over? Analysis of 5.3 million individuals in England and Wales from 2020-2022
Research Square 2024cited by 0position: middledoi
Use of sodium valproate and other antiseizure drug treatments in England and Wales: quantitative analysis of nationwide linked electronic health records
BMJ Medicine 2024cited by 0position: middledoi
The impact of the COVID-19 pandemic on cardiovascular disease prevention and management
Nature Medicine 2023cited by 133position: middledoi
Use of Sodium Valproate and Other Anti-Seizure Medications in England and Wales During the COVID-19 Pandemic: A Population-Level Analysis of 60 Million Individuals
SSRN Electronic Journal 2023cited by 2position: middledoi
The Impact of the COVID-19 Pandemic on the Measurement of Routine Cardiometabolic Disease Risk Factors in Primary Care in the Population of England (57 Million People)
SSRN Electronic Journal 2023cited by 1position: middledoi
Association of COVID-19 With Major Arterial and Venous Thrombotic Diseases: A Population-Wide Cohort Study of 48 Million Adults in England and Wales
Circulation 2022cited by 289position: middledoi
COVID-19 trajectories among 57 million adults in England: a cohort study using electronic health records
The Lancet Digital Health 2022cited by 83position: middledoi
Using national electronic health records for pandemic preparedness: validation of a parsimonious model for predicting excess deaths among those with COVID-19–a data-driven retrospective cohort study
Journal of the Royal Society of Medicine 2022cited by 7position: middledoi
The adverse impact of COVID-19 pandemic on cardiovascular disease prevention and management in England, Scotland and Wales: A population-scale analysis of trends in medication data
medRxiv 2022cited by 7position: middledoi
Using National Electronic Health Records for Pandemic Preparedness: Validation of a Parsimonious Model for Predicting Excess Deaths Among Those With COVID-19
SSRN Electronic Journal 2022cited by 1position: middledoi
Using National Electronic Health Records for Pandemic Preparedness: Validation of a Parsimonious Model for Predicting Excess Deaths Among Those With COVID-19
SSRN Electronic Journal 2022cited by 0position: middledoi
Vaccinating adolescents against SARS-CoV-2 in England: a risk–benefit analysis
Journal of the Royal Society of Medicine 2021cited by 43position: middledoi
Association of COVID-19 with arterial and venous vascular diseases: a population-wide cohort study of 48 million adults in England and Wales
medRxiv 2021cited by 10position: middledoi
Understanding COVID-19 trajectories from a nationwide linked electronic health record cohort of 56 million people: phenotypes, severity, waves & vaccination
medRxiv 2021cited by 3position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Spiros Denaxas · National and Kapodistrian University of Athens11 papers (2021–2025)Cathie Sudlow · British Heart Foundation9 papers (2021–2025)Kamlesh Khunti · University Hospitals of North Midlands NHS Trust9 papers (2022–2025)Amitava Banerjee · University College Hospital8 papers (2021–2025)Ashley Akbari · Swansea University8 papers (2021–2025)Johan H. Thygesen · University College London7 papers (2021–2025)Sara Khalid · Helwan University6 papers (2022–2025)Mehrdad A. Mizani · University of Edinburgh6 papers (2021–2024)Harry Hemingway · Health Data Research UK6 papers (2021–2025)Reecha Sofat · University of Liverpool5 papers (2021–2024)Thomas Bolton · University of Cambridge5 papers (2022–2025)Fatemeh Torabi · Health Data Research UK5 papers (2022–2024)Álex Handy · University of London4 papers (2021–2022)Alvina G. Lai · University of London4 papers (2021–2022)Mark Ashworth · King's College London4 papers (2023–2024)Laura Pasea · Barts Health NHS Trust4 papers (2022–2024)Caroline Dale · London School of Hygiene & Tropical Medicine4 papers (2023–2024)Mary Joan MacLeod · University of Edinburgh3 papers (2022–2022)Dexter Canoy · Newcastle University3 papers (2022–2022)Colin Berry · Onze Lieve Vrouwziekenhuis Hospital3 papers (2022–2022)